When the U.S. Food and Drug Administration (U.S. FDA) announced the final rule on changes to the National Drug Code (NDC) in March, it signaled a major shift for the pharmaceutical industry. But what does the rule really mean in practice? Hear directly from the U.S. FDA as they break down the final rule and its implications for drug identification. This session will explore how the changes may impact packaging, barcoding, and supply chain systems and what organizations should be thinking about now. Leave with clearer insight into the rule and practical ideas for turning regulatory change into an operational benefit.